Cita APA (7a ed.)

Kuno, I., Takayanagi, D., Asami, Y., Murakami, N., Matsuda, M., Shimada, Y., . . . Kato, T. (2021). TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer. Nature Portfolio.

Cita Chicago Style (17a ed.)

Kuno, Ikumi, et al. TP53 Mutants and Non-HPV16/18 Genotypes Are Poor Prognostic Factors for Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Kuno, Ikumi, et al. TP53 Mutants and Non-HPV16/18 Genotypes Are Poor Prognostic Factors for Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer. Nature Portfolio, 2021.